Atlas Trials

Primitive Neuroectodermal Tumor

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Primitive Neuroectodermal Tumor

RecordFirmDate
Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer (NCT04521946)M.D. Anderson Cancer Center2021-01-14
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors (NCT04185038)Seattle Children's Hospital2019-12-11
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors (NCT03638167)Seattle Children's Hospital2019-03-19
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors (NCT03500991)Seattle Children's Hospital2018-07-26
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors (NCT03434262)St. Jude Children's Research Hospital2018-03-05
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors (NCT02508038)University of Wisconsin, Madison2016-02-12
Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors (NCT00983398)OHSU Knight Cancer Institute2009-07-09

Track Primitive Neuroectodermal Tumor automatically

Every clearance here is in the API, with alerts when new ones post.